Tag Archives: Thomas Riermeier

Evonik’s EUDRAGIT® Polymers: Pioneering Pharmaceutical Innovation for 70 Years

(IN BRIEF) Evonik’s EUDRAGIT® polymers, renowned coatings for pharmaceuticals, celebrate 70 years of revolutionizing drug delivery. With over 23,000 patents and 10,000 scientific publications, these methacrylate polymers have become industry standards, employed in formulations for modified drug release across 80 … Read the full press release

Evonik to Introduce New Class of rPEG Lipids for Enhanced Immunogenicity in Drug Delivery

(IN BRIEF) Evonik has partnered with the University of Mainz to commercialize a new class of polyethylene glycols (PEGs) called randomized polyethylene glycols (rPEGs). These rPEGs will be integrated into Evonik’s specialized lipid platform for drug delivery in nucleic acid-based … Read the full press release

Evonik’s Health Care Site in France Achieves Carbon Neutrality, Advancing Sustainable Practices

(IN BRIEF) Evonik’s Health Care production site in Ham, France, has achieved carbon neutrality by reducing its direct and indirect greenhouse gas emissions to zero. This milestone aligns with Evonik Health Care’s commitment to becoming carbon neutral in Scope 1 … Read the full press release

Evonik expands lipid manufacturing capabilities for advanced drug delivery

(IN BRIEF) Specialty chemicals company Evonik has opened a lipid launch facility at its site in Hanau, Germany. The good manufacturing practice facility, which opened on 8 March 2023, will enable Evonik to provide customers with quantities of lipids as … Read the full press release

Evonik to acquire company for innovative biomaterials for medical device technologies

Nanostructured biomaterial for wound dressings and dermatology to be integrated into Health Care business Evonik Venture Capital’s early investment in 2015 pays off Evonik aims to more than double the share of system solutions in Nutrition & Care by 2030 … Read the full press release